Amanat Acquisition Corp. - 8-K Filing
Amanat Acquisition Corp. enters into a definitive business combination agreement with Corxel Pharmaceuticals, Inc. valued at an implied equity value of $200 million. (Items: 1.01 Entry Into A Material Definitive Agreement On October 25, 2026, Amanat Acquisition Corp, a Cayman Islands exempted company (“AMAN”), Cairo Me, 3.02 Unregistered Sales of Equity Securities, 7.01 Regulation FD Disclosure, 9.01 Financial Statements and Exhibits)
Tickers: $AMAN
Read the full article at SEC EDGAR
Part of the story Zeo ScientifiX, Inc. - 8-K Filing (3 articles)